Nitric oxide signaling: no longer simply on or off

Trends in Biochemical Sciences

Volumn 31, Issue 4, 2006, Pages 231-239

  Cary, Stephen P L ^a   Winger, Jonathan A ^b   Derbyshire, Emily R ^c   Marletta, Michael A ^a,c,d  

^a Department of Chemistry ^*  (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; BACTERIAL PROTEIN; CYCLIC GMP; GUANYLATE CYCLASE; HEMOPROTEIN; NITRIC OXIDE; OXYGEN; PROTEIN HISTIDINE KINASE; PROTEIN SUBUNIT;

AMINO TERMINAL SEQUENCE; CAENORHABDITIS ELEGANS; CARBOXY TERMINAL SEQUENCE; CHEMICAL ANALYSIS; CLOSTRIDIUM BOTULINUM; DROSOPHILA MELANOGASTER; ENZYME ACTIVATION; ENZYME ACTIVITY; EUKARYOTE; HYDROGEN BOND; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROKARYOTE; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; SMOOTH MUSCLE; THERMOANAEROBACTER;

ANIMALS; CYCLIC GMP; GUANYLATE CYCLASE; HEME; HUMANS; MODELS, CHEMICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIGNAL TRANSDUCTION;

EUKARYOTA; PROKARYOTA;

EID: 33645959194     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2006.02.003     Document Type: Review

References (75)

1. 2. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 355-360
2. Bredt D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res. 31 (1999) 577-596
3. Dawson V.L., and Dawson T.M. Nitric oxide in neurodegeneration. Prog. Brain Res. 118 (1998) 215-229
4. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J. Gastroenterol. 38 (2003) 421-430
5. Kurtz A., and Wagner C. Role of nitric oxide in the control of renin secretion. Am. J. Physiol. 275 (1998) F849-F862
6. Cals-Grierson M.M., and Ormerod A.D. Nitric oxide function in the skin. Nitric Oxide 10 (2004) 179-193
7. Koglin M., et al. Nitric oxide activates the β2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J. Biol. Chem. 276 (2001) 30737-30743
8. Wedel B., et al. Mutation of His-105 in the β1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 2592-2596
9. Zhao Y., and Marletta M.A. Localization of the heme binding region in soluble guanylate cyclase. Biochemistry 36 (1997) 15959-15964
10. Zhao Y., et al. Identification of histidine 105 in the β1 subunit of soluble guanylate cyclase as the heme proximal ligand. Biochemistry 37 (1998) 4502-4509
11. Wedel B., et al. Functional domains of soluble guanylyl cyclase. J. Biol. Chem. 270 (1995) 24871-24875
12. Iyer L.M., et al. Ancient conserved domains shared by animal soluble guanylyl cyclases and bacterial signaling proteins. BMC Genomics 4 (2003) 5
13. Karow D.S., et al. Spectroscopic characterization of the soluble guanylate cyclase-like heme domains from Vibrio cholerae and Thermoanaerobacter tengcongensis. Biochemistry 43 (2004) 10203-10211
14. Karow D.S., et al. Characterization of functional heme domains from soluble guanylate cyclase. Biochemistry 44 (2005) 16266-16274
15. Nioche P., et al. Femtomolar sensitivity of a NO sensor from Clostridium botulinum. Science 306 (2004) 1550-1553
16. Gray J.M., et al. Oxygen sensation and social feeding mediated by a C. elegans guanylate cyclase homologue. Nature 430 (2004) 317-322
17. Kelley L.A., et al. Enhanced genome annotation using structural profiles in the program 3D-PSSM. J. Mol. Biol. 299 (2000) 499-520
18. Winger J.A., and Marletta M.A. Expression and characterization of the catalytic domains of soluble guanylate cyclase: interaction with the heme domain. Biochemistry 44 (2005) 4083-4090
19. Schulz S. C-type natriuretic peptide and guanylyl cyclase B receptor. Peptides 26 (2005) 1024-1034
20. Tremblay J., et al. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol. Cell. Biochem. 230 (2002) 31-47
21. Pellicena P., et al. Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 12854-12859
22. Boon E.M., et al. A molecular basis for NO selectivity in soluble guanylate cyclase. Nature Chem Biol. 1 (2005) 53-59
23. Boon E.M., and Marletta M.A. Ligand discrimination in soluble guanylate cyclase and the H-NOX family of heme sensor proteins. Curr. Opin. Chem. Biol. 9 (2005) 441-446
24. Boon E.M., and Marletta M.A. Ligand specificity of H-NOX domains: from sGC to bacterial NO sensors. J. Inorg. Biochem. 99 (2005) 892-902
25. Morton D.B. Atypical soluble guanylyl cyclases in Drosophila can function as molecular oxygen sensors. J. Biol. Chem. 279 (2004) 50651-50653
26. Hetz S.K., and Bradley T.J. Insects breathe discontinuously to avoid oxygen toxicity. Nature 433 (2005) 516-519
27. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
28. Gruetter C.A., et al. Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosoamine. J. Cyclic Nucleotide Res. 5 (1979) 211-224
29. Ignarro L.J., et al. Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ. Res. 61 (1987) 866-879
30. Katsuki S., et al. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3 (1977) 23-35
31. Lewicki J.A., et al. Purified guanylate cyclase: characterization, iodination and preparation of monoclonal antibodies. J. Cyclic Nucleotide Res. 6 (1980) 283-296
32. Ignarro L.J., et al. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim. Biophys. Acta 718 (1982) 49-59
33. Stone J.R., and Marletta M.A. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33 (1994) 5636-5640
34. Stone J.R., and Marletta M.A. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35 (1996) 1093-1099
35. Zhao Y., et al. A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 14753-14758
36. Bellamy T.C., and Garthwaite J. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells. J. Biol. Chem. 276 (2001) 4287-4292
37. Bellamy T.C., et al. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 2928-2933
38. Cary S.P., et al. Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13064-13069
39. Russwurm M., and Koesling D. NO activation of guanylyl cyclase. EMBO J. 23 (2004) 4443-4450
40. Makino R., et al. EPR characterization of axial bond in metal center of native and cobalt-substituted guanylate cyclase. J. Biol. Chem. 274 (1999) 7714-7723
41. Brandish P.E., et al. Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin. Biochemistry 37 (1998) 16898-16907
42. Kharitonov V.G., et al. Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. Biochemistry 36 (1997) 6814-6818
43. Kharitonov V.G., et al. Dissociation of nitric oxide from soluble guanylate cyclase. Biochem. Biophys. Res. Commun. 239 (1997) 284-286
44. Margulis A., and Sitaramayya A. Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium. Biochemistry 39 (2000) 1034-1039
45. Xue L., et al. Carbon monoxide and nitric oxide as coneurotransmitters in the enteric nervous system: evidence from genomic deletion of biosynthetic enzymes. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1851-1855
46. Cary S.P., and Marletta M.A. The case of CO signaling: why the jury is still out. J. Clin. Invest. 107 (2001) 1071-1073
47. Chang F.J., et al. Nitric oxide-dependent allosteric inhibitory role of a second nucleotide binding site in soluble guanylyl cyclase. J. Biol. Chem. 280 (2005) 11513-11519
48. Lamothe M., et al. Functional characterization of nitric oxide and YC-1 activation of soluble guanylyl cyclase: structural implication for the YC-1 binding site?. Biochemistry 43 (2004) 3039-3048
49. Suzuki T., et al. Organic phosphates as a new class of soluble guanylate cyclase inhibitors. FEBS Lett. 507 (2001) 49-53
50. Ruiz-Stewart I., et al. Guanylyl cyclase is an ATP sensor coupling nitric oxide signaling to cell metabolism. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 37-42
51. Brunori M. Nitric oxide moves myoglobin centre stage. Trends Biochem. Sci. 26 (2001) 209-210
52. Godecke A., et al. Myoglobin protects the heart from inducible nitric-oxide synthase (iNOS)-mediated nitrosative stress. J. Biol. Chem. 278 (2003) 21761-21766
53. Martin W., et al. Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. J. Pharmacol. Exp. Ther. 237 (1986) 529-538
54. Buvinic S., and Huidobro-Toro J.P. Basal tonic release of nitric oxide coupled to cGMP production regulates the vascular reactivity of the mesenteric bed. Eur. J. Pharmacol. 424 (2001) 221-227
55. Palmer R.M., et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
56. Hare J.M., and Colucci W.S. Role of nitric oxide in the regulation of myocardial function. Prog. Cardiovasc. Dis. 38 (1995) 155-166
57. Shah A.M., and MacCarthy P.A. Paracrine and autocrine effects of nitric oxide on myocardial function. Pharmacol. Ther. 86 (2000) 49-86
58. Toda N., and Okamura T. The pharmacology of nitric oxide in the peripheral nervous system of blood vessels. Pharmacol. Rev. 55 (2003) 271-324
59. Bon C.L., and Garthwaite J. On the role of nitric oxide in hippocampal long-term potentiation. J. Neurosci. 23 (2003) 1941-1948
60. Bernabeu R., et al. Role of hippocampal NO in the acquisition and consolidation of inhibitory avoidance learning. Neuroreport 6 (1995) 1498-1500
61. Bernabeu R., et al. Further evidence for the involvement of a hippocampal cGMP/cGMP-dependent protein kinase cascade in memory consolidation. Neuroreport 8 (1997) 2221-2224
62. Chien W.L., et al. Enhancement of long-term potentiation by a potent nitric oxide-guanylyl cyclase activator, 3-(5-hydroxymethyl-2-furyl)-1-benzyl-indazole. Mol. Pharmacol. 63 (2003) 1322-1328
63. Chien W.L., et al. Enhancement of learning behaviour by a potent nitric oxide-guanylate cyclase activator YC-1. Eur. J. Neurosci. 21 (2005) 1679-1688
64. Hurley J.H. The adenylyl and guanylyl cyclase superfamily. Curr. Opin. Struct. Biol. 8 (1998) 770-777
65. Tesmer J.J., and Sprang S.R. The structure, catalytic mechanism and regulation of adenylyl cyclase. Curr. Opin. Struct. Biol. 8 (1998) 713-719
66. Wu C.C., et al. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol. 116 (1995) 1973-1978
67. Friebe A., and Koesling D. Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol. Pharmacol. 53 (1998) 123-127
68. Stone J.R., and Marletta M.A. Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem. Biol. 5 (1998) 255-261
69. Denninger J.W., et al. Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies. Biochemistry 39 (2000) 4191-4198
70. Makino R., et al. YC-1 facilitates release of the proximal His residue in the NO and CO complexes of soluble guanylate cyclase. J. Biol. Chem. 278 (2003) 11130-11137
71. Pal B., et al. Resonance Raman study on synergistic activation of soluble guanylate cyclase by imidazole, YC-1 and GTP. J. Inorg. Biochem. 98 (2004) 824-832
72. Pal B., and Kitagawa T. Interactions of soluble guanylate cyclase with diatomics as probed by resonance Raman spectroscopy. J. Inorg. Biochem. 99 (2005) 267-279
73. Derbyshire E.R., et al. Characterization of nitrosoalkane binding and activation of soluble guanylate cyclase. Biochemistry 44 (2005) 16257-16265
74. Stasch J.P., et al. NO-independent regulatory site on soluble guanylate cyclase. Nature 410 (2001) 212-215
75. Stasch J.P., et al. NO- and haem-independent activation of soluble guanylyl cyclase: molecular basis and cardiovascular implications of a new pharmacological principle. Br. J. Pharmacol. 136 (2002) 773-783